There is now scientific proof that we have the potential to use our mind to heal ourselves! Studies of the mind/body connection and of the power of the body's intention to heal itself are revolutionising approaches to healing.
There is now scientific proof that we have the potential to use our mind to heal ourselves! Studies of the mind/body connection and of the power of the body's intention to heal itself are revolutionising approaches to healing.
There is now scientific proof that we have the potential to use our mind to heal ourselves! Studies of the mind/body connection and of the power of the body's intention to heal itself are revolutionising approaches to healing.
There is now scientific proof that we have the potential to use our mind to heal ourselves! Studies of the mind/body connection and of the power of the body's intention to heal itself are revolutionising approaches to healing.
Boston Scientific Corporation (NYSE: BSX) introduces its CardioTeach™ iPad® app, an industry-first, free educational resource to help healthcare professionals better educate patients and caregivers about therapy options related to cardiovascular and peripheral diseases, specifically atrial and ventricular arrhythmias, coronary artery disease, heart failure, heart rhythm disorders and peripheral vascular disease.
To view Multimedia News Release, go to http://www.multivu.com/mnr/43509-boston-scientific-cardioteach-ipad-app
Living Proof launches its latest scientific breakthrough in hair care: Restore.
Remember your hair when you were a kid? It was shiny, smooth, soft and strong – the envy of your Mom. It wasn’t fussed over. It barely needed to be brushed. But years of blow drying, flat ironing, teasing, bleaching and coloring have left your hair dry and damaged.
Youthful hair is naturally healthy, beautiful hair. We all had it once. What if you could bring it back?
To view Multimedia News Release, go to http://www.multivu.com/mnr/52656-living-proof-restore-salvation-for-dry-or-damaged-hair
Boston Scientific Corporation (NYSE: BSX) announces positive clinical data from the Research in Severe Asthma (RISA) Trial, demonstrating the long-term safety of bronchial thermoplasty (BT) in patients treated with the Company’s AlairTM Bronchial Thermoplasty System. Follow-up data demonstrate that stable lung function is maintained and late clinical complications are absent over a five-year period in patients with severe refractory asthma treated with BT. Results were presented today at the annual European Respiratory Society (ERS) Congress in Amsterdam by Michel Laviolette, M.D., Professor of Medicine, Institut universitaire de cardiologie et de pneumologie at Université Laval in Québec City, Canada.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/bostonscientific/52128/
Primal Mist has released two new perfumes, Formulae Alpha and Formulae Beta, after four years of archaeological study, scientific investigation and fragrance design. The Primal Mist line is produced in extremely small quantities, making them exclusive and rare. The company states that each stage of the creation process is hand-crafted, including bottling. Both perfumes are cured for two years before they are ready for release.
To view Multimedia News Release, go to http://www.multivu.com/mnr/51941-primal-mist-releases-formulae-alpha-beta-fragrances-american-perfumer
Shake Weight, the nation’s most talked about, best-selling and most parodied fitness craze, is the centerpiece of a newly-released independent study that proves the world-famous arm-sculpting device is no laughing matter.
FitnessIQ, marketers of the Shake Weight, today disclosed findings of a scientific study conducted by Dr. Jeffrey M. Willardson, an Associate Biomechanics Professor at Eastern Illinois University (EIU). The study evaluated the effects of incorporating a six-minute Shake Weight routine in the warm-up sessions of three Division I collegiate athletic teams, measuring the device’s impact on performance. The study demonstrated that athletes across all three sports, including baseball, volleyball and soccer, improved reaction time by 10% to 17%.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/fitnessiq/50394/
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and haemodynamic monitoring, announced the results of a pivotal clinical study of high-risk surgical patients with severe aortic stenosis treated in Cohort A of The PARTNER Trial. These data demonstrate that the study achieved its primary endpoint at one year, concluding that survival of patients treated with the Edwards SAPIEN transcatheter aortic valve was equivalent to those treated with surgical aortic valve replacement. The data were presented at the American College of Cardiology’s (ACC) 60th Annual Scientific Session & Expo in New Orleans, LA, USA.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/prne/edwardslifesciences/48895/
Five Hundred hairdressers from across the country took to the streets of New York City on December 1st—World AIDS Day 2010—to launch ‘Hairdressers Against AIDS’ in the United States. Hairdressers Against AIDS is a global advocacy program that aims to empower the entire industry of hairdressers and salon professionals to use their unique relationship with their clients to become a resource to interact, educate and help prevent the spread of HIV. Hairdressers Against AIDS (U.S.) is sponsored by The L’Oréal Fondation D’Enterprise in partnership with the United Nations Educational, Scientific and Cultural Organization (UNESCO) and the Global Business Coalition on HIV/AIDS, TB and Malaria (GBC), and is believed to be one of the largest HIV/AIDS mobilization campaigns in U.S. history.
To view Mulimedia News Release, go to http://multivu.prnewswire.com/mnr/hairdressersagainstaids/47483/
Lancôme is unveiling Genes Day on October 22, a one day fundraiser in support of St. Jude Children’s Research Hospital.
In celebration of the beauty of scientific research, Lancôme will donate $7 from each bottle of their latest skin care breakthrough, Génifique Youth Activating Concentrate, sold that day to St. Jude Children’s Research Hospital to support the research and treatment at St. Jude.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/lancome/46646/
